S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
Can Netflix Stock Continue Into All-Time Highs After Earnings?
Shares of Walmart-backed Ibotta soar on public debut

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
$0.17
+6.2%
$0.19
$0.16
$1.09
$5.12M0.191.98 million shs729,302 shs
CryoLife, Inc. stock logo
CRY
CryoLife
$19.05
$16.95
$32.34
$703.22M1.53198,221 shs7,792 shs
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
$29.46
-1.5%
$28.15
$23.10
$53.50
$711.21M1.16178,894 shs81,159 shs
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
$5.25
$6.52
$4.38
$8.45
$401.68M0.15728,762 shs658,320 shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
+5.52%-3.85%-9.99%-2.77%-75.78%
CryoLife, Inc. stock logo
CRY
CryoLife
0.00%0.00%0.00%0.00%0.00%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-1.47%-6.65%+10.71%+2.15%-38.59%
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
0.00%-9.01%-21.99%-32.52%-23.69%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
N/AN/AN/AN/AN/AN/AN/AN/A
CryoLife, Inc. stock logo
CRY
CryoLife
N/AN/AN/AN/AN/AN/AN/AN/A
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
4.0418 of 5 stars
3.41.00.03.92.84.20.6
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
3.9857 of 5 stars
2.25.00.04.21.81.71.9

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
N/AN/AN/AN/A
CryoLife, Inc. stock logo
CRY
CryoLife
N/AN/AN/AN/A
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
2.75
Moderate Buy$42.5044.26% Upside
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
2.33
Hold$6.3821.43% Upside

Current Analyst Ratings

Latest AFIB, KIDS, OSUR, and CRY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/10/2024
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$37.00
4/4/2024
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetIn-Line ➝ In-Line$7.00 ➝ $6.50
3/7/2024
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Outperform ➝ Market Outperform$50.00
1/25/2024
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold$39.00 ➝ $31.00
(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
$7.16M0.71N/AN/A($0.03) per share-5.74
CryoLife, Inc. stock logo
CRY
CryoLife
$253.23M0.00N/A23.30$8.46 per share0.00
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
$148.73M4.71N/AN/A$16.14 per share1.83
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
$405.47M0.99$1.34 per share3.92$5.86 per share0.90

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
-$81.66M-$1.24N/AN/A-166.79%-35.31%-13.43%5/9/2024 (Estimated)
CryoLife, Inc. stock logo
CRY
CryoLife
-$16.68M$0.03596.200.00N/A0.63%4.24%1.63%N/A
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-$20.97M-$0.92N/AN/AN/A-14.10%-5.03%-4.37%5/6/2024 (Estimated)
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
$53.65M$0.727.29N/AN/A13.23%14.50%12.69%5/8/2024 (Estimated)

Latest AFIB, KIDS, OSUR, and CRY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/6/2024Q4 2023
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-$0.28-$0.23+$0.05-$0.17$37.59 million$37.61 million
2/27/2024Q4 2023
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
$0.13$0.22+$0.09$0.17$74.13 million$75.88 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
N/AN/AN/AN/AN/A
CryoLife, Inc. stock logo
CRY
CryoLife
N/AN/AN/AN/AN/A
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
N/AN/AN/AN/AN/A
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
1.10
2.44
2.22
CryoLife, Inc. stock logo
CRY
CryoLife
0.99
4.21
2.93
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
0.03
5.44
2.90
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
N/A
9.77
8.57

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
56.91%
CryoLife, Inc. stock logo
CRY
CryoLife
81.57%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
69.05%
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
93.50%

Insider Ownership

CompanyInsider Ownership
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
3.50%
CryoLife, Inc. stock logo
CRY
CryoLife
4.50%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
32.60%
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
3.40%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
23029.72 million28.68 millionOptionable
CryoLife, Inc. stock logo
CRY
CryoLife
1,20039.33 million37.56 millionOptionable
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
24723.79 million16.03 millionOptionable
OraSure Technologies, Inc. stock logo
OSUR
OraSure Technologies
63876.51 million73.91 millionOptionable

AFIB, KIDS, OSUR, and CRY Headlines

SourceHeadline
Files taken from Orasure systems in cybersecurity incidentFiles taken from Orasure systems in cybersecurity incident
medtechdive.com - April 17 at 5:08 PM
OraSure Technologies Experiences “Cybersecurity Incident” and Investigates Possible Data BreachOraSure Technologies Experiences “Cybersecurity Incident” and Investigates Possible Data Breach
jdsupra.com - April 17 at 2:07 AM
OraSure reports data breach, says impact containedOraSure reports data breach, says impact contained
investing.com - April 14 at 12:25 AM
OraSure Technologies Hit With Cybersecurity BreachOraSure Technologies Hit With Cybersecurity Breach
marketwatch.com - April 12 at 6:04 PM
OraSure reports cybersecurity breach, says incident has been containedOraSure reports cybersecurity breach, says incident has been contained
msn.com - April 12 at 6:04 PM
OraSure Technologies, Inc. (NASDAQ:OSUR) Short Interest UpdateOraSure Technologies, Inc. (NASDAQ:OSUR) Short Interest Update
marketbeat.com - April 12 at 4:32 PM
OraSure Technologies (NASDAQ:OSUR) & Carmell (NASDAQ:CTCX) Critical SurveyOraSure Technologies (NASDAQ:OSUR) & Carmell (NASDAQ:CTCX) Critical Survey
americanbankingnews.com - April 11 at 1:15 AM
OraSure Technologies (NASDAQ:OSUR) Price Target Lowered to $6.50 at Evercore ISIOraSure Technologies (NASDAQ:OSUR) Price Target Lowered to $6.50 at Evercore ISI
marketbeat.com - April 4 at 1:51 PM
Announcing speakers for the 2024 Builders Conference and Signature EventAnnouncing speakers for the 2024 Builders Conference and Signature Event
technical.ly - March 30 at 9:13 AM
OraSure Technologies, Inc. (OSUR)OraSure Technologies, Inc. (OSUR)
finance.yahoo.com - March 29 at 12:30 PM
Singapores DBS bank confident of 15%-17% ROE in next 3-5 years, CEO saysSingapore's DBS bank confident of 15%-17% ROE in next 3-5 years, CEO says
sg.finance.yahoo.com - March 28 at 9:28 PM
OraSure Technologies, Inc.s (NASDAQ:OSUR) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?OraSure Technologies, Inc.'s (NASDAQ:OSUR) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
finance.yahoo.com - March 28 at 11:23 AM
Pacer Advisors Inc. Increases Stake in OraSure Technologies, Inc. (NASDAQ:OSUR)Pacer Advisors Inc. Increases Stake in OraSure Technologies, Inc. (NASDAQ:OSUR)
marketbeat.com - March 27 at 6:12 AM
NOWDiagnostics Welcomes Dr. Stephen S. Tang as Chairman of the BoardNOWDiagnostics Welcomes Dr. Stephen S. Tang as Chairman of the Board
finance.yahoo.com - March 21 at 9:26 AM
OSUR Oct 2024 10.000 callOSUR Oct 2024 10.000 call
finance.yahoo.com - March 16 at 7:56 AM
OSUR Jul 2024 5.000 putOSUR Jul 2024 5.000 put
finance.yahoo.com - March 16 at 7:56 AM
OraSure Technologies Full Year 2023 Earnings: EPS Beats ExpectationsOraSure Technologies Full Year 2023 Earnings: EPS Beats Expectations
finance.yahoo.com - March 1 at 9:50 AM
OraSure Technologies, Inc. (NASDAQ:OSUR) Q4 2023 Earnings Call TranscriptOraSure Technologies, Inc. (NASDAQ:OSUR) Q4 2023 Earnings Call Transcript
finance.yahoo.com - February 28 at 9:55 AM
Q4 2023 OraSure Technologies Inc Earnings CallQ4 2023 OraSure Technologies Inc Earnings Call
finance.yahoo.com - February 28 at 9:55 AM
OraSure Technologies: Q4 Earnings InsightsOraSure Technologies: Q4 Earnings Insights
benzinga.com - February 27 at 5:28 PM
OraSure Technologies Non-GAAP EPS of $0.22 beats by $0.11, revenue of $75.88M beats by $1.61MOraSure Technologies Non-GAAP EPS of $0.22 beats by $0.11, revenue of $75.88M beats by $1.61M
msn.com - February 27 at 5:28 PM
OraSure Technologies Inc (OSUR) Reports Q4 Revenue Decline Amidst Strategic Growth EffortsOraSure Technologies Inc (OSUR) Reports Q4 Revenue Decline Amidst Strategic Growth Efforts
finance.yahoo.com - February 27 at 5:28 PM
OraSure Reports Q4 ‘23 Revenue of $75.9 MillionOraSure Reports Q4 ‘23 Revenue of $75.9 Million
globenewswire.com - February 27 at 4:05 PM
OraSure to report fourth-quarter earnings, hold conference call Tuesday after close of marketsOraSure to report fourth-quarter earnings, hold conference call Tuesday after close of markets
wfmz.com - February 26 at 9:26 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Acutus Medical logo

Acutus Medical

NASDAQ:AFIB
Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. The company was incorporated in 2011 and is headquartered in Carlsbad, California.
CryoLife logo

CryoLife

NYSE:CRY
CryoLife, Inc. engages in the manufacture, process and distribution of medical devices and implantable human tissues. It operates through the Medical Devices and Preservation Services segments. The Medical Devices segment includes revenues from sales of BioGlue products, aortic stents and stent grafts, On-X products, CardioGenesis cardiac laser therapy, PerClot, and PhotoFix. The Preservation Services segment focuses on revenues from preservation of cardiac and vascular implantable human tissues. The company was founded on January 19, 1984 and is headquartered in Kennesaw, GA.
OrthoPediatrics logo

OrthoPediatrics

NASDAQ:KIDS
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
OraSure Technologies logo

OraSure Technologies

NASDAQ:OSUR
OraSure Technologies, Inc., together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company's products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands for collecting genetic material from human saliva; Colli-Pee collection devices for the volumetric collection of void urine samples; and microbiome laboratory testing and analytical services. In addition, the company provides microbiome products, such as OMNIgene GUT for self-collecting microbial DNA from feces or stool samples for gut microbiome profiling; OMNIgene GUT DNA and RNA collection devices; and OMNIgene GUT Dx collection device for collection of human fecal samples and the stabilization of DNA from the bacterial community. Additionally, it provides other diagnostic products, such as immunoassays and other in vitro diagnostic tests. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, commercial and industrial entities, disease risk management, diagnostics, pharmaceutical, biotech, nutrition, companion animal, and environmental markets. OraSure Technologies, Inc. was incorporated in 2000 and is based in Bethlehem, Pennsylvania.